Jimi Olaghere/LinkedIn
Jun 24, 2026, 16:09
Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
Jimi Olaghere, Co-Founder at Sugarloaf Capital, shared a post on LinkedIn:
“It’s not too late to register for this free hybrid event hosted by NHLBI – Blood Research and Education and Sickle Cell Disease Association of America, Inc. — National.
I’ve seen firsthand what happens when researchers, clinicians, patients, and families work together – It needs to be the standard.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation